Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis

OBJECTIVE: To examine whether rituximab induction followed by glatiramer acetate (GA) monotherapy is more effective than GA alone for the treatment of relapsing multiple sclerosis with active disease. METHODS: This was a single-center, double-blind, placebo-controlled study. Fifty-five participants...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurology
Autori principali: Honce, Justin M., Nair, Kavita V., Sillau, Stefan, Valdez, Brooke, Miravalle, Augusto, Alvarez, Enrique, Schreiner, Teri, Corboy, John R., Vollmer, Timothy L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6382366/
https://ncbi.nlm.nih.gov/pubmed/30635477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000006916
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi